ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
JGC Holdings, an engineering company headquartered in Yokohama, Japan, has been awarded a contract by Chugai Pharmaceutical to build an active pharmaceutical ingredient (API) manufacturing plant for clinical- and early-stage commercial biologic drugs. The plant, to be constructed at Chugai’s facility in Utsunomiya, Tochigi Prefecture, will include continuous production functions as well as batch manufacturing. The facility is scheduled for completion in 2026.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter